Skip to main content
Daan Gene Co., Ltd. logo

Daan Gene Co., Ltd. — Investor Relations & Filings

Ticker · 002030 ISIN · CNE000001KP1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,189 across all filing types
Latest filing 2025-10-30 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002030

About Daan Gene Co., Ltd.

https://www.daangene.com

Daan Gene Co., Ltd. specializes in the development and manufacturing of molecular diagnostic products and services. The company focuses on in vitro diagnostic technologies, particularly polymerase chain reaction (PCR) platforms. Its product portfolio includes diagnostic kits for infectious diseases, genetic screening, and oncology, alongside automated nucleic acid extraction systems and real-time PCR instruments. Daan Gene provides comprehensive solutions for clinical laboratories and public health institutions, integrating research, production, and clinical testing services. The organization emphasizes technological innovation in molecular biology to support precision medicine and disease control.

Recent filings

Filing Released Lang Actions
内部审计制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '内部审计制度' (Internal Audit System) and details the internal audit policies, procedures, responsibilities, and organizational structure of Guangzhou Da An Gene Co., Ltd. It is a comprehensive internal governance document focused on internal audit functions rather than financial results or external reporting. There is no indication that this is an audit report issued by external auditors, nor is it a financial report like an annual or interim report. It is also not a regulatory filing or announcement. The content aligns with governance and internal control practices, which fits best under Governance Information (CGR). The document length is 4741 characters, which is substantive and contains detailed policy content, not a brief announcement or certification.
2025-10-30 Chinese
信息披露暂缓与豁免制度（2025年10月）
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled 'Information Disclosure Delay and Exemption System' for Guangzhou Da An Gene Co., Ltd. It outlines procedures, legal compliance, internal approval processes, and management of information disclosure exemptions and delays. It does not contain financial data, earnings, audit results, or regulatory filings per se. It is not an announcement of a report but a governance-related internal rules document. Therefore, it fits best under Governance Information (CGR). The document length is 2611 characters, which is relatively short but contains substantive governance content rather than a mere announcement or certification.
2025-10-30 Chinese
工程项目管理制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '工程项目管理制度' which translates to 'Engineering Project Management System' and contains detailed internal policies and procedures related to engineering project management within the company Guangzhou Da An Gene Co., Ltd. It outlines rules, responsibilities, approval procedures, and administrative controls for engineering projects. There is no indication that this is a financial report, audit, earnings release, or any regulatory filing. It is an internal governance or management policy document. It does not fit into categories like Annual Report, Interim Report, or Regulatory Filings. The closest fitting category is Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is about internal governance of engineering projects, which aligns with CGR. The document length is 2437 characters, which is not extremely short, and it is not an announcement of a report but the policy itself. Therefore, the classification is Governance Information (CGR) with high confidence.
2025-10-30 Chinese
董事会审计委员会工作细则（2025年10月）
Governance Information Classification · 95% confidence The document is titled as the "Board Audit Committee Working Rules" of Guangzhou Da An Gene Co., Ltd. It details the composition, responsibilities, decision-making procedures, and operational rules of the audit committee under the board of directors. The content focuses on governance structure, audit oversight, internal control supervision, and committee meeting protocols. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, and no earnings information. The document is a governance-related internal regulation document, specifying the audit committee's role and procedures, which fits the definition of Governance Information (CGR). The document length is 4069 characters, which is not extremely short, and it is not an announcement of a report publication. Therefore, the correct classification is Governance Information (CGR) with high confidence.
2025-10-30 Chinese
关于调整自有资金现金管理品种的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Da An Gene Co., Ltd. regarding an adjustment to the company's cash management investment products. It details decisions made at the company's board meetings and shareholder meeting, specifically about the types of financial products used for managing idle funds. The document includes information about the investment risk, risk control measures, and the impact of the adjustment on the company. It is a formal announcement of a financing or capital management update rather than a full financial report or earnings release. The document length is short (1693 characters), and it does not contain financial statements or detailed financial data. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2025-10-30 Chinese
上市公司独立董事提名人声明与承诺（刘焕亮）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by the nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with laws and regulations, and independence criteria for the nominee. There is no financial data, no report of financial performance, no voting results, no management changes announcement, and no mention of shareholder votes or meeting materials. The document is a nomination statement related to board composition, specifically about an independent director candidate. This fits best under Board/Management Information (MANG), which covers announcements of changes or nominations in the company's board of directors or senior management.
2025-10-30 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.